Mangoceuticals (MGRX) Net Income (2023 - 2026)

Mangoceuticals' Net Income history runs 4 years deep, the most recent figure standing at -$3.4 million for Q1 2026.

• In Q1 2026, Net Income rose 29.68% year-over-year to -$3.4 million; the TTM figure through Mar 2026 stood at -$19.2 million (down 71.81% YoY), while the FY2025 annual figure was -$20.6 million, down 137.08% from the prior year.
• Net Income came in at -$3.4 million for Q1 2026 at Mangoceuticals, down from -$2.8 million in the prior quarter.
• In the past five years, Net Income ranged from a high of -$1.8 million in Q3 2023 to a low of -$7.6 million in Q3 2025.
• A 4-year average of -$3.2 million and a median of -$2.6 million in 2023 frame the typical range for Net Income.
• Across the five-year window, Net Income plunged 281.0% in 2025 and increased 29.68% in 2026, its largest moves.
• Mangoceuticals' Net Income stood at -$2.6 million in 2023, then grew by 24.12% to -$1.9 million in 2024, then slumped by 42.12% to -$2.8 million in 2025, then dropped by 22.89% to -$3.4 million in 2026.
• According to Business Quant data, Net Income over the past three periods registered -$3.4 million, -$2.8 million, and -$7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison